ppanPersonalized Psychiatry and NeurologyPersonalized Psychiatry and Neurology2712-9179V. M. Bekhterev National Medical Research Centre for Psychiatry and Neurology of the Ministry of Health of the Russian Federation (Bekhterev NMRC PN)10.52667/2712-9179-2024-4-3-24-36ppan-109Research ArticleREVIEWAnimal Models of Vascular Cognitive Disorder after Myocardial Infarction: Scoping ReviewPetrovA. V.

Artem V. Petrov

660022 Krasnoyarsk

ShnayderN. A.

Natalia A. Shnayder

660022 Krasnoyarsk

192019 Saint Petersburg

naschnaider@yandex.ruPetrovaM. M.

Marina M. Petrova

660022 Krasnoyarsk

stk99@yandex.ruEvsyukovA. A.

Aleksandr A. Evsyukov

660022 Krasnoyarsk

KaskaevaD. S.

 Darya S. Kaskaeva

660022 Krasnoyarsk

DmitrenkoD. V.

Diana V. Dmitrenko

660022 Krasnoyarsk

MalinovskayaN. A.

 Natalia A. Malinovskaya

660022 Krasnoyarsk

V.F. Voino-Yasenetsky Krasnoyarsk State Medical UniversityRussian FederationV.F. Voino-Yasenetsky Krasnoyarsk State Medical University; V.M. Bekhterev National Medical Research Centre for Psychiatry and NeurologyRussian Federation202418092024432436Copyright © Petrov A.V., Shnayder N.A., Petrova M.M., Evsyukov A.A., Kaskaeva D.S., Dmitrenko D.V., Malinovskaya N.A., 20242024Petrov A.V., Shnayder N.A., Petrova M.M., Evsyukov A.A., Kaskaeva D.S., Dmitrenko D.V., Malinovskaya N.A.Petrov A.V., Shnayder N.A., Petrova M.M., Evsyukov A.A., Kaskaeva D.S., Dmitrenko D.V., Malinovskaya N.A.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.jppn.ru/jour/article/view/109

Vascular cognitive disorders (VCD) are one of the most common forms of non-psychotic mental disorders with a variable phenotype and rate of progression, transformation into vascular dementia. VCD is characterized by development against the background of existing cardiovascular diseases (CVD), which explains the importance of an interdisciplinary approach to their diagnosis and treatment. The study of new mechanisms of development of VCD can help in finding the key to the development of innovative diagnostic methods and personalized treatment approaches. The purpose of this thematic review is to search, generalize and systematize domestic and foreign research in the field of fundamental neurology using methods of modeling VCD in experimental animals. The authors conducted a search for publications in the databases PubMed, Springer, Web of Science, Clinical Keys, Scopus, Oxford Press, Cochrane, e-Library using keywords and their combinations. The publications for 2005-2024 were analyzed, including original studies of VCD and vascular dementia.

fundamental neurologycognitive functionsvascular cognitive disordersexperimentanimal modeldisease modelingVoino-Yasenetsky Krasnoyarsk State Medical University National of the Ministry of Health of Russia 2022 - 2025 (“Development of a personalized algorithm for diagnosing vascular moderate cognitive dysfunction against the background of acute myocardial infarction based on new genetic and biochemical biomarkers”, No. 123022800057-6).ReferencesVerdelho, A.; Wardlaw, J.; Pavlovic, A.; Pantoni, L.; Godefroy, O.; Duering, M.; Charidimou, A.; Chabriat, H.; Biessels, G.J. Cognitive impairment in patients with cerebrovascular disease: A white paper from the links between stroke ESO Dementia Committee. Eur Stroke J. 2021, 6(1): 5-17. doi: 10.1177/23969873211000258Verdelho, A.; Wardlaw, J.; Pavlovic, A.; Pantoni, L.; Godefroy, O.; Duering, M.; Charidimou, A.; Chabriat, H.; Biessels, G.J. Cognitive impairment in patients with cerebrovascular disease: A white paper from the links between stroke ESO Dementia Committee. Eur Stroke J. 2021, 6(1): 5-17. doi: 10.1177/23969873211000258Kalaria, R.N. Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for alzheimer's disease. Acta Neuropathol. 2016, 131: 659–685. doi: 10.1007/s00401-016-1571-zKalaria, R.N. Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for alzheimer's disease. Acta Neuropathol. 2016, 131: 659–685. doi: 10.1007/s00401-016-1571-zGavrilova, E.S.; Yashina, L.M. Evaluation of cardiovascular risk factors and educational technologies of the correction in youth population. Siberian Medical Review. 2017, (2): 48-55. doi: 10.20333/2500136-2017-2-48-55. (In Russian)Gavrilova, E.S.; Yashina, L.M. Evaluation of cardiovascular risk factors and educational technologies of the correction in youth population. Siberian Medical Review. 2017, (2): 48-55. doi: 10.20333/2500136-2017-2-48-55. (In Russian)Balasubramanian, P.; DelFavero, J.; Ungvari, A.; Papp, M.; Tarantini, A.; Price, N.; de Cabo, R.; Tarantini, S. Time-restricted feeding (TRF) for prevention of age-related vascular cognitive impairment and dementia. Ageing Res Rev. 2020, 64:101189. doi: 10.1016/j.arr.2020.101189Balasubramanian, P.; DelFavero, J.; Ungvari, A.; Papp, M.; Tarantini, A.; Price, N.; de Cabo, R.; Tarantini, S. Time-restricted feeding (TRF) for prevention of age-related vascular cognitive impairment and dementia. Ageing Res Rev. 2020, 64:101189. doi: 10.1016/j.arr.2020.101189Wolters, F.J.; Ikram, M.A. Epidemiology of vascular dementia. Arterioscler Thromb Vasc Biol. 2019, 39:1542–1549. doi: 10.1161/ATVBAHA.119.311908Wolters, F.J.; Ikram, M.A. Epidemiology of vascular dementia. Arterioscler Thromb Vasc Biol. 2019, 39:1542–1549. doi: 10.1161/ATVBAHA.119.311908Ministry of Health of the Russian Federation. Clinical recommendations. Cognitive disorders in the elderly and senile. https://cr.minzdrav.gov.ru/schema/617_1 (In Russian)Ministry of Health of the Russian Federation. Clinical recommendations. Cognitive disorders in the elderly and senile. https://cr.minzdrav.gov.ru/schema/617_1 (In Russian)Iadecola, C.; Duering, M.; Hachinski, V.; Joutel, A.; Pendlebury, S.T.; Schneider, J.A., Dichgans M. Vascular cognitive impairment and dementia: JACC scientific expert panel. J Am Coll Cardiol. 2019, 73(25):3326-3344. doi: 10.1016/j.jacc.2019.04.034Iadecola, C.; Duering, M.; Hachinski, V.; Joutel, A.; Pendlebury, S.T.; Schneider, J.A., Dichgans M. Vascular cognitive impairment and dementia: JACC scientific expert panel. J Am Coll Cardiol. 2019, 73(25):3326-3344. doi: 10.1016/j.jacc.2019.04.034Parfenov, V.A. Diagnosis and treatment of vascular cognitive impairment, the use of citicoline: A review. Consilium Medicum. 2024, 26(2):112-116. doi: 10.26442/20751753.2024.2.202719. (In Russian)Parfenov, V.A. Diagnosis and treatment of vascular cognitive impairment, the use of citicoline: A review. Consilium Medicum. 2024, 26(2):112-116. doi: 10.26442/20751753.2024.2.202719. (In Russian)Chang Wong, E.; Chang Chui, H. Vascular cognitive impairment and dementia. Continuum (Minneap Minn). 2022, 28(3): 750-780. doi:10.1212/CON.0000000000001124Chang Wong, E.; Chang Chui, H. Vascular cognitive impairment and dementia. Continuum (Minneap Minn). 2022, 28(3): 750-780. doi:10.1212/CON.0000000000001124Rundek, T.; Tolea, M.; Ariko, T.; Fagerli, E.A.; Camargo, C.J. Vascular cognitive impairment (VCI). Neurotherapeutics. 2022, 19(1):68-88. doi:10.1007/s13311-021-01170-y]Rundek, T.; Tolea, M.; Ariko, T.; Fagerli, E.A.; Camargo, C.J. Vascular cognitive impairment (VCI). Neurotherapeutics. 2022, 19(1):68-88. doi:10.1007/s13311-021-01170-y]Yang, Y.; Kimura-Ohba, S.; Thompson, J.; Rosenberg, G.A. Rodent models of vascular cognitive impairment. Transl Stroke Res. 2016, 7(5):407-414. doi:10.1007/s12975-016-0486-2Yang, Y.; Kimura-Ohba, S.; Thompson, J.; Rosenberg, G.A. Rodent models of vascular cognitive impairment. Transl Stroke Res. 2016, 7(5):407-414. doi:10.1007/s12975-016-0486-2Weng, Z.; Cao, C.; Stepicheva, N.A.; Chen, F.; Foley, L.M.; Cao, S.; Bhuiyan, M.I.H.; Wang, Q.; Wang, Y.; Hitchens, T. K.; Sun, D.; Cao, G.A. Novel needle mouse model of vascular cognitive impairment and dementia. The Journal of Neuroscience 2023, 43(44):7351–7360. doi: 10.1523/JNEUROSCI.0282-23.2023Weng, Z.; Cao, C.; Stepicheva, N.A.; Chen, F.; Foley, L.M.; Cao, S.; Bhuiyan, M.I.H.; Wang, Q.; Wang, Y.; Hitchens, T. K.; Sun, D.; Cao, G.A. Novel needle mouse model of vascular cognitive impairment and dementia. The Journal of Neuroscience 2023, 43(44):7351–7360. doi: 10.1523/JNEUROSCI.0282-23.2023Dorofeikova, M.V.; Petrova, N.N.; Egorov, A.Yu. Animal models of cognitive impairment in neurodegenerative and organic disorders. Russian Journal of Physiology 2020, 106(2):157–175. doi: 10.31857/S086981392002003XDorofeikova, M.V.; Petrova, N.N.; Egorov, A.Yu. Animal models of cognitive impairment in neurodegenerative and organic disorders. Russian Journal of Physiology 2020, 106(2):157–175. doi: 10.31857/S086981392002003XStewart, A.M.; Kalueff, A.V. Developing better and more valid animal models of brain disorders. Behav. Brain Res. 2015, 276:28-31. doi: 10.1016/j.bbr.2013.12.024Stewart, A.M.; Kalueff, A.V. Developing better and more valid animal models of brain disorders. Behav. Brain Res. 2015, 276:28-31. doi: 10.1016/j.bbr.2013.12.024Thong, E.H.E.; Quek, E.J.W.; Loo, J.H.; Yun, C.Y.; Teo, Y.N.; Teo, Y.H.; Leow, A.S.T.; Li, T.Y.W.; Sharma, V.K.; Tan, B.Y.Q.; Yeo, L.L.L.; Chong, Y.F.; Chan, M.Y.; Sia, C.H. Acute myocardial infarction and risk of cognitive impairment and dementia: A review. Biology (Basel) 2023, 12(8):1154. doi: 10.3390/biology12081154Thong, E.H.E.; Quek, E.J.W.; Loo, J.H.; Yun, C.Y.; Teo, Y.N.; Teo, Y.H.; Leow, A.S.T.; Li, T.Y.W.; Sharma, V.K.; Tan, B.Y.Q.; Yeo, L.L.L.; Chong, Y.F.; Chan, M.Y.; Sia, C.H. Acute myocardial infarction and risk of cognitive impairment and dementia: A review. Biology (Basel) 2023, 12(8):1154. doi: 10.3390/biology12081154Leto, L.; Feola, M. Cognitive impairment in heart failure patients. J. Geriatr. Cardiol. 2014, 11:316–328. doi: 10.11909/j.issn.1671-5411.2014.04.007Leto, L.; Feola, M. Cognitive impairment in heart failure patients. J. Geriatr. Cardiol. 2014, 11:316–328. doi: 10.11909/j.issn.1671-5411.2014.04.007Barnes, J.M.; Barnes, N.M.; Costall, B.; Horovitz, Z.P.; Ironside, J.W.; Naylor, R.J.; Williams, T.J. Angiotensin II inhibits cortical cholinergic function: Implications for cognition. J. Cardiovasc. Pharmacol. 1990, 16:234–238. doi: 10.1097/00005344-199008000-00009Barnes, J.M.; Barnes, N.M.; Costall, B.; Horovitz, Z.P.; Ironside, J.W.; Naylor, R.J.; Williams, T.J. Angiotensin II inhibits cortical cholinergic function: Implications for cognition. J. Cardiovasc. Pharmacol. 1990, 16:234–238. doi: 10.1097/00005344-199008000-00009Savaskan, E.; Hock, C.; Olivieri, G.; Bruttel, S.; Rosenberg, C.; Hulette, C.; Müller-Spahn, F. Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer’s dementia. Neurobiol. Aging. 2001, 22:541–546. doi: 10.1016/S0197-4580(00)00259-1Savaskan, E.; Hock, C.; Olivieri, G.; Bruttel, S.; Rosenberg, C.; Hulette, C.; Müller-Spahn, F. Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer’s dementia. Neurobiol. Aging. 2001, 22:541–546. doi: 10.1016/S0197-4580(00)00259-1Tooze, J.A.; Gaussoin, S.A.; Resnick, S.M.; Fischbein, N.J.; Robinson, J.G.; Bryan, R.N.; An, Y.; Espeland, M.A. A uniform approach to modeling risk factor relationships for ischemic lesion prevalence and extent: The Women’s Health Initiative magnetic resonance imaging study. Neuroepidemiology 2010, 34:55–62. doi: 10.1159/000260071Tooze, J.A.; Gaussoin, S.A.; Resnick, S.M.; Fischbein, N.J.; Robinson, J.G.; Bryan, R.N.; An, Y.; Espeland, M.A. A uniform approach to modeling risk factor relationships for ischemic lesion prevalence and extent: The Women’s Health Initiative magnetic resonance imaging study. Neuroepidemiology 2010, 34:55–62. doi: 10.1159/000260071Kuller, L.H.; Margolis, K.L.; Gaussoin, S.A.; Bryan, N.R.; Kerwin, D.; Limacher, M.; Wassertheil-Smoller, S.; Williamson, J.; Robinson, J.G.; Group, W.H.I.M.S.R. Relationship of hypertension, blood pressure, and blood pressure control with white matter abnormalities in the Women’s Health Initiative Memory Study (WHIMS)—MRI trial. J. Clin. Hypertens. 2010, 12: 203–212. doi: 10.1111/j.1751-7176.2009.00234.xKuller, L.H.; Margolis, K.L.; Gaussoin, S.A.; Bryan, N.R.; Kerwin, D.; Limacher, M.; Wassertheil-Smoller, S.; Williamson, J.; Robinson, J.G.; Group, W.H.I.M.S.R. Relationship of hypertension, blood pressure, and blood pressure control with white matter abnormalities in the Women’s Health Initiative Memory Study (WHIMS)—MRI trial. J. Clin. Hypertens. 2010, 12: 203–212. doi: 10.1111/j.1751-7176.2009.00234.xIadecola, C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 2010, 120:287–296. doi: 10.1007/s00401-010-0718-6Iadecola, C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 2010, 120:287–296. doi: 10.1007/s00401-010-0718-6Lecrux, C.; Hamel, E. The neurovascular unit in brain function and disease. Acta Physiol. 2011, 203:47–59. doi: 10.1111/j.1748-1716.2011.02256.xLecrux, C.; Hamel, E. The neurovascular unit in brain function and disease. Acta Physiol. 2011, 203:47–59. doi: 10.1111/j.1748-1716.2011.02256.xZlokovic, B.V. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat. Rev. Neurosci. 2011, 12:723–738. doi: 10.1038/nrn3114Zlokovic, B.V. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat. Rev. Neurosci. 2011, 12:723–738. doi: 10.1038/nrn3114Tan, Z.S.; Beiser, A.S.; Vasan, R.S.; Roubenoff, R.; Dinarello, C.A.; Harris, T.B.; Benjamin, E.J.; Au, R.; Kiel, D.P.; Wolf, P.A. Inflammatory markers and the risk of Alzheimer disease: The Framingham Study. Neurology 2007, 68:1902–1908. doi: 10.1212/01.wnl.0000263217.36439.daTan, Z.S.; Beiser, A.S.; Vasan, R.S.; Roubenoff, R.; Dinarello, C.A.; Harris, T.B.; Benjamin, E.J.; Au, R.; Kiel, D.P.; Wolf, P.A. Inflammatory markers and the risk of Alzheimer disease: The Framingham Study. Neurology 2007, 68:1902–1908. doi: 10.1212/01.wnl.0000263217.36439.daTan, Z.S.; Beiser, A.S.; Fox, C.S.; Au, R.; Himali, J.J.; Debette, S.; DeCarli, C.; Vasan, R.S.; Wolf, P.A.; Seshadri, S. Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: The Framingham Offspring Study. Diabetes Care 2011, 34:1766–1770. doi: 10.2337/dc11-0308Tan, Z.S.; Beiser, A.S.; Fox, C.S.; Au, R.; Himali, J.J.; Debette, S.; DeCarli, C.; Vasan, R.S.; Wolf, P.A.; Seshadri, S. Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: The Framingham Offspring Study. Diabetes Care 2011, 34:1766–1770. doi: 10.2337/dc11-0308Sundbøll, J.; Horváth-Puhó, E.; Adelborg, K.; Schmidt, M.; Pedersen, L.; Bøtker, H.E.; Henderson, V.W.; Sørensen, H.T. Higher Risk of vascular dementia in myocardial infarction survivors. Circulation 2018, 137:567–577. doi: 10.1161/CIRCULATIONAHA.117.029127Sundbøll, J.; Horváth-Puhó, E.; Adelborg, K.; Schmidt, M.; Pedersen, L.; Bøtker, H.E.; Henderson, V.W.; Sørensen, H.T. Higher Risk of vascular dementia in myocardial infarction survivors. Circulation 2018, 137:567–577. doi: 10.1161/CIRCULATIONAHA.117.029127Alosco, M.L.; Hayes, S.M. Structural brain alterations in heart failure: A review of the literature and implications for risk of Alzheimer’s disease. Heart Fail. Rev. 2015, 20:561–571. doi: 10.1007/s10741-015-9488-5Alosco, M.L.; Hayes, S.M. Structural brain alterations in heart failure: A review of the literature and implications for risk of Alzheimer’s disease. Heart Fail. Rev. 2015, 20:561–571. doi: 10.1007/s10741-015-9488-5Alves, T.C.T.F.; Rays, J.; Fráguas, R.J.; Wajngarten, M.; Meneghetti, J.C.; Prando, S.; Busatto, G.F. Localized cerebral blood flow reductions in patients with heart failure: A study using 99mTc-HMPAO SPECT. J. Neuroimaging Off. J. Am. Soc. Neuroimaging. 2005, 15:150–156. doi: 10.1177/1051228404272880Alves, T.C.T.F.; Rays, J.; Fráguas, R.J.; Wajngarten, M.; Meneghetti, J.C.; Prando, S.; Busatto, G.F. Localized cerebral blood flow reductions in patients with heart failure: A study using 99mTc-HMPAO SPECT. J. Neuroimaging Off. J. Am. Soc. Neuroimaging. 2005, 15:150–156. doi: 10.1177/1051228404272880Almeida, J.R.C.; Alves, T.C.T.F.; Wajngarten, M.; Rays, J.; Castro, C.C.; Cordeiro, Q.; Telles, R.M.S.; Fraguas, R.J.; Busatto, G.F. Late-life depression, heart failure and frontal white matter hyperintensity: A structural magnetic resonance imaging study. Braz. J. Med. Biol. Res. 2005, 38:431–436. doi: 10.1590/S0100-879X2005000300014Almeida, J.R.C.; Alves, T.C.T.F.; Wajngarten, M.; Rays, J.; Castro, C.C.; Cordeiro, Q.; Telles, R.M.S.; Fraguas, R.J.; Busatto, G.F. Late-life depression, heart failure and frontal white matter hyperintensity: A structural magnetic resonance imaging study. Braz. J. Med. Biol. Res. 2005, 38:431–436. doi: 10.1590/S0100-879X2005000300014Stegmann, T.; Chu, M.L.; Witte, V.A.; Villringer, A.; Kumral, D.; Riedel-Heller, S.G.; Roehr, S.; Hagendorff, A.; Laufs, U.; Loeffler, M. Heart failure is independently associated with white matter lesions: Insights from the population-based LIFEAdult Study. ESC Heart Fail. 2021, 8:697–704. doi: 10.1002/ehf2.13166Stegmann, T.; Chu, M.L.; Witte, V.A.; Villringer, A.; Kumral, D.; Riedel-Heller, S.G.; Roehr, S.; Hagendorff, A.; Laufs, U.; Loeffler, M. Heart failure is independently associated with white matter lesions: Insights from the population-based LIFEAdult Study. ESC Heart Fail. 2021, 8:697–704. doi: 10.1002/ehf2.13166Ikram, M.A.; van Oijen, M.; de Jong, F.J.; Kors, J.A., Koudstaal, P.J.; Hofman, A.; Witteman, J.C.M.; Breteler, M.M.B. Unrecognized myocardial infarction in relation to risk of dementia and cerebral small vessel disease. Stroke 2008, 39:1421–1426. doi: 10.1161/STROKEAHA.107.501106Ikram, M.A.; van Oijen, M.; de Jong, F.J.; Kors, J.A., Koudstaal, P.J.; Hofman, A.; Witteman, J.C.M.; Breteler, M.M.B. Unrecognized myocardial infarction in relation to risk of dementia and cerebral small vessel disease. Stroke 2008, 39:1421–1426. doi: 10.1161/STROKEAHA.107.501106Thackeray, J.T.; Hupe, H.C.; Wang, Y.; Bankstahl, J.P.; Berding, G.; Ross, T.L.; Bauersachs, J.; Wollert, K.C.; Bengel, F.M. Myocardial Inflammation Predicts Remodeling and Neuroinflammation After Myocardial Infarction. J. Am. Coll. Cardiol. 2018, 71:263–275. doi: 10.1016/j.jacc.2017.11.024Thackeray, J.T.; Hupe, H.C.; Wang, Y.; Bankstahl, J.P.; Berding, G.; Ross, T.L.; Bauersachs, J.; Wollert, K.C.; Bengel, F.M. Myocardial Inflammation Predicts Remodeling and Neuroinflammation After Myocardial Infarction. J. Am. Coll. Cardiol. 2018, 71:263–275. doi: 10.1016/j.jacc.2017.11.024Goh, F.Q.; Kong, W.K.F.; Wong, R.C.C.; Chong, Y.F.; Chew, N.W.S.; Yeo, T.-C.; Sharma, V.K.; Poh, K.K.; Sia, C.-H. Cognitive Impairment in Heart Failure-A Review. Biology 2022, 11:179. doi: 10.3390/biology11020179Goh, F.Q.; Kong, W.K.F.; Wong, R.C.C.; Chong, Y.F.; Chew, N.W.S.; Yeo, T.-C.; Sharma, V.K.; Poh, K.K.; Sia, C.-H. Cognitive Impairment in Heart Failure-A Review. Biology 2022, 11:179. doi: 10.3390/biology11020179Georgiadis, D.; Sievert, M.; Cencetti, S.; Uhlmann, F.; Krivokuca, M.; Zierz, S.; Werdan, K. Cerebrovascular reactivity is impaired in patients with cardiac failure. Eur. Heart J. 2000, 21:407–413. doi: 10.1053/euhj.1999.1742Georgiadis, D.; Sievert, M.; Cencetti, S.; Uhlmann, F.; Krivokuca, M.; Zierz, S.; Werdan, K. Cerebrovascular reactivity is impaired in patients with cardiac failure. Eur. Heart J. 2000, 21:407–413. doi: 10.1053/euhj.1999.1742Gruhn, N.; Larsen, F.S.; Boesgaard, S.; Knudsen, G.M.; Mortensen, S.A.; Thomsen, G.; Aldershvile, J. Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke 2001, 32:2530–2533. doi: 10.1161/hs1101.098360Gruhn, N.; Larsen, F.S.; Boesgaard, S.; Knudsen, G.M.; Mortensen, S.A.; Thomsen, G.; Aldershvile, J. Cerebral blood flow in patients with chronic heart failure before and after heart transplantation. Stroke 2001, 32:2530–2533. doi: 10.1161/hs1101.098360De Jong, G.I.; Farkas, E.; Stienstra, C.M.; Plass, J.R.; Keijser, J.N.; de la Torre, J.C.; Luiten, P.G. Cerebral hypoperfusion yields capillary damage in the hippocampal CA1 area that correlates with spatial memory impairment. Neuroscience 1999, 91:203– 210. doi: 10.1016/S0306-4522(98)00659-9De Jong, G.I.; Farkas, E.; Stienstra, C.M.; Plass, J.R.; Keijser, J.N.; de la Torre, J.C.; Luiten, P.G. Cerebral hypoperfusion yields capillary damage in the hippocampal CA1 area that correlates with spatial memory impairment. Neuroscience 1999, 91:203– 210. doi: 10.1016/S0306-4522(98)00659-9Kure, C.E.; Rosenfeldt, F.L.; Scholey, A.B.; Pipingas, A.; Kaye, D.M.; Bergin, P.J.; Croft, K.D.; Wesnes, K.A.; Myers, S.P.; Stough, C. Relationships among cognitive function and cerebral blood flow, oxidative stress, and inflammation in older heart failure patients. J. Card. Fail. 2016, 22:548–559. doi: 10.1016/j.cardfail.2016.03.006Kure, C.E.; Rosenfeldt, F.L.; Scholey, A.B.; Pipingas, A.; Kaye, D.M.; Bergin, P.J.; Croft, K.D.; Wesnes, K.A.; Myers, S.P.; Stough, C. Relationships among cognitive function and cerebral blood flow, oxidative stress, and inflammation in older heart failure patients. J. Card. Fail. 2016, 22:548–559. doi: 10.1016/j.cardfail.2016.03.006Yang, T.; Lu, Z.; Wang, L.; Zhao, Y.; Nie, B.; Xu, Q.; Han, X.; Li, T.; Zhao, J.; Cheng, W.; Wang, B.; Wu, A.; Zhu, H.; Meng, W.; Shang, H.; Zhao, M. Dynamic changes in brain glucose metabolism and neuronal structure in rats with heart failure. Neuroscience 2020, 424:34–44. doi: 10.1016/j.neuroscience.2019.10.008Yang, T.; Lu, Z.; Wang, L.; Zhao, Y.; Nie, B.; Xu, Q.; Han, X.; Li, T.; Zhao, J.; Cheng, W.; Wang, B.; Wu, A.; Zhu, H.; Meng, W.; Shang, H.; Zhao, M. Dynamic changes in brain glucose metabolism and neuronal structure in rats with heart failure. Neuroscience 2020, 424:34–44. doi: 10.1016/j.neuroscience.2019.10.008Meissner, A.; Visanji, N.P.; Momen, M.A.; Feng, R.; Francis, B.M.; Bolz, S.; Hazrati, L. Tumor necrosis factor-α underlies loss of cortical dendritic spine density in a mouse model of congestive heart failure. J. Am. Heart Assoc. 2015, 4:e001920. doi: 10.1161/JAHA.115.001920Meissner, A.; Visanji, N.P.; Momen, M.A.; Feng, R.; Francis, B.M.; Bolz, S.; Hazrati, L. Tumor necrosis factor-α underlies loss of cortical dendritic spine density in a mouse model of congestive heart failure. J. Am. Heart Assoc. 2015, 4:e001920. doi: 10.1161/JAHA.115.001920Sudduth, T.L.; Powell, D.K.; Smith, C.D.; Greenstein, A.; Wilcock, D.M. Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation. J. Cereb. Blood. Flow. Metab. 2013, 33(5): 708–715. doi: 10.1038/jcbfm.2013.1Sudduth, T.L.; Powell, D.K.; Smith, C.D.; Greenstein, A.; Wilcock, D.M. Induction of hyperhomocysteinemia models vascular dementia by induction of cerebral microhemorrhages and neuroinflammation. J. Cereb. Blood. Flow. Metab. 2013, 33(5): 708–715. doi: 10.1038/jcbfm.2013.1Gooch, J.; Wilcock, D.M. Animal models of vascular cognitive impairment and dementia (VCID). Cell Mol Neurobiol. 2016, 36(2):233-239. doi: 10.1007/s10571-015-0286-3Gooch, J.; Wilcock, D.M. Animal models of vascular cognitive impairment and dementia (VCID). Cell Mol Neurobiol. 2016, 36(2):233-239. doi: 10.1007/s10571-015-0286-3Hattori, Y.; Enmi, J.; Kitamura, A.; Yamamoto, Y.; Saito, S.; Takahashi, Y. A novel mouse model of subcortical infarcts with dementia. J. Neurosci. 2015, 35(9):3915-3928. doi: 10.1523/JNEUROSCI.3970-14.2015Hattori, Y.; Enmi, J.; Kitamura, A.; Yamamoto, Y.; Saito, S.; Takahashi, Y. A novel mouse model of subcortical infarcts with dementia. J. Neurosci. 2015, 35(9):3915-3928. doi: 10.1523/JNEUROSCI.3970-14.2015Neto, C.J.B.F.; Paganelli, R.A.; Benetoli, A.; Lima, K.C.M.; Milani, H. Permanent, 3-stage, 4-vessel occlusion as a model of chronic and progressive brain hypoperfusion in rats: a neurohistological and behavioral analysis. Behav Brain Res. 2005, 160(2):312-322. doi: 10.1016/j.bbr.2004.12.016Neto, C.J.B.F.; Paganelli, R.A.; Benetoli, A.; Lima, K.C.M.; Milani, H. Permanent, 3-stage, 4-vessel occlusion as a model of chronic and progressive brain hypoperfusion in rats: a neurohistological and behavioral analysis. Behav Brain Res. 2005, 160(2):312-322. doi: 10.1016/j.bbr.2004.12.016Jiwa, N.S.; Garrard, P.; Hainsworth, A.H. Experimental models of vascular dementia and vascular cognitive impairment: a systematic review. J. Neurochem. 2010, 115(4):814-828. doi: 10.1111/j.1471-4159.2010.06958.xJiwa, N.S.; Garrard, P.; Hainsworth, A.H. Experimental models of vascular dementia and vascular cognitive impairment: a systematic review. J. Neurochem. 2010, 115(4):814-828. doi: 10.1111/j.1471-4159.2010.06958.xNiedowicz, D.M.; Reeves, V.L.; Platt, T.L.; Kohler, K.; Beckett, T.L.; Powell, D.K.; Lee, T.L.; Sexton, T.R.; Song, E.S.; Brewer, L.D.; Latimer, C.S.; Kraner, S.D.; Larson, K.L.; Ozcan, S.; Norris, C.M.; Hersh, L.B.; Porter, N.M.; Wilcock, D.M.; Murphy, M.P. Obesity and diabetes cause cognitive dysfunction in the absence of accelerated β-amyloid deposition in a novel murine model of mixed or vascular dementia. Acta Neuropathol Commun. 2014, 2: 64. doi: 10.1186/2051-5960-2-64Niedowicz, D.M.; Reeves, V.L.; Platt, T.L.; Kohler, K.; Beckett, T.L.; Powell, D.K.; Lee, T.L.; Sexton, T.R.; Song, E.S.; Brewer, L.D.; Latimer, C.S.; Kraner, S.D.; Larson, K.L.; Ozcan, S.; Norris, C.M.; Hersh, L.B.; Porter, N.M.; Wilcock, D.M.; Murphy, M.P. Obesity and diabetes cause cognitive dysfunction in the absence of accelerated β-amyloid deposition in a novel murine model of mixed or vascular dementia. Acta Neuropathol Commun. 2014, 2: 64. doi: 10.1186/2051-5960-2-64Cognat, E.; Cleophax, S.; Domenga-Denier, V.; Joutel, A. Early white matter changes in CADASIL: evidence of segmental intramyelinic oedema in a pre-clinical mouse model. Acta Neuropathol Commun. 2014, 2:49. doi: 10.1186/2051-5960-2-49Cognat, E.; Cleophax, S.; Domenga-Denier, V.; Joutel, A. Early white matter changes in CADASIL: evidence of segmental intramyelinic oedema in a pre-clinical mouse model. Acta Neuropathol Commun. 2014, 2:49. doi: 10.1186/2051-5960-2-49Neha; Sodhi, R.K.; Jaggi, A.S.; Singh, N. Animal models of dementia and cognitive dysfunction. Life Sci. 2014, 109(2): 73-86. doi: 10.1016/j.lfs.2014.05.017Neha; Sodhi, R.K.; Jaggi, A.S.; Singh, N. Animal models of dementia and cognitive dysfunction. Life Sci. 2014, 109(2): 73-86. doi: 10.1016/j.lfs.2014.05.017Zhang, X.; Le, W. Pathological role of hypoxia in Alzheimer’s disease. Exp Neurol. 2010, 223(2):299-303. doi: 10.1016/j.expneurol.2009.07.033Zhang, X.; Le, W. Pathological role of hypoxia in Alzheimer’s disease. Exp Neurol. 2010, 223(2):299-303. doi: 10.1016/j.expneurol.2009.07.033Malick, M.; Gilbert, K.; Brouillette, J.; Godbout, R.; Rousseau, G. Cognitive deficits following a post-myocardial infarct in the rat are blocked by the serotonin-norepinephrine reuptake inhibitor desvenlafaxine. Int J Mol Sci. 2018, 19(12):3748. doi: 10.3390/ijms19123748Malick, M.; Gilbert, K.; Brouillette, J.; Godbout, R.; Rousseau, G. Cognitive deficits following a post-myocardial infarct in the rat are blocked by the serotonin-norepinephrine reuptake inhibitor desvenlafaxine. Int J Mol Sci. 2018, 19(12):3748. doi: 10.3390/ijms19123748Drake, C.; Boutin, H.; Jones, M.S.; Denes, A.; McColl, B.W.; Selvarajah, J.R.; Hulme, S.; Georgiou, R.F.; Hinz, R.; Gerhard, A.; Vail, A.; Prenant, C.; Julyan, P.; Maroy, R.; Brown, G.; Smigova, A.; Herholz, K.; Kassiou, M.; Crossman, D.; Francis, S.; Proctor, S.D.; Russell, J.C.; Hopkins, S.J.; Tyrrell, P.J.; Rothwell, N.J.; Allan, S.M. Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav Immun. 2011, 25(6):1113-1122. doi: 10.1016/j.bbi.2011.02.008Drake, C.; Boutin, H.; Jones, M.S.; Denes, A.; McColl, B.W.; Selvarajah, J.R.; Hulme, S.; Georgiou, R.F.; Hinz, R.; Gerhard, A.; Vail, A.; Prenant, C.; Julyan, P.; Maroy, R.; Brown, G.; Smigova, A.; Herholz, K.; Kassiou, M.; Crossman, D.; Francis, S.; Proctor, S.D.; Russell, J.C.; Hopkins, S.J.; Tyrrell, P.J.; Rothwell, N.J.; Allan, S.M. Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav Immun. 2011, 25(6):1113-1122. doi: 10.1016/j.bbi.2011.02.008Li, J.G.; Praticò, D. High levels of homocysteine results in cerebral amyloid angiopathy in mice. J Alzheimers Dis. 2015, 43(1): 29-35. doi: 10.3233/JAD-141101Li, J.G.; Praticò, D. High levels of homocysteine results in cerebral amyloid angiopathy in mice. J Alzheimers Dis. 2015, 43(1): 29-35. doi: 10.3233/JAD-141101Sudduth, T.L.; Weekman, E.M.; Brothers, H.M.; Braun, K.; Wilcock, D.M. β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice. Alzheimers Res Ther. 2014, 6(3):32. doi: 10.1186/alzrt262Sudduth, T.L.; Weekman, E.M.; Brothers, H.M.; Braun, K.; Wilcock, D.M. β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice. Alzheimers Res Ther. 2014, 6(3):32. doi: 10.1186/alzrt262Sebastian, M.J.; Khan, S.K.; Pappachan, J.M.; Jeeyavudeen, M.S. Diabetes and cognitive function: An evidence-based current perspective. World J Diabetes 2023, 14(2):92-109. doi: 10.4239/wjd.v14.i2.92.Sebastian, M.J.; Khan, S.K.; Pappachan, J.M.; Jeeyavudeen, M.S. Diabetes and cognitive function: An evidence-based current perspective. World J Diabetes 2023, 14(2):92-109. doi: 10.4239/wjd.v14.i2.92.Saedi, E.; Gheini, M.R.; Faiz, F.; Arami, M.A. Diabetes mellitus and cognitive impairments. World J Diabetes 2016, 7(17):412- 422. doi: 10.4239/wjd.v7.i17.412Saedi, E.; Gheini, M.R.; Faiz, F.; Arami, M.A. Diabetes mellitus and cognitive impairments. World J Diabetes 2016, 7(17):412- 422. doi: 10.4239/wjd.v7.i17.412Martinez, J.L.Jr.; Jensen, R.A.; Vasquez, B.J.; Lacob, J.S.; McGaugh, J.L.; Purdy, R.E. Acquisition deficits induced by sodium nitrite in rats and mice. Psychopharmacology (Berl). 1979, 60(3):221–228. doi:10.1007/bf00426659Martinez, J.L.Jr.; Jensen, R.A.; Vasquez, B.J.; Lacob, J.S.; McGaugh, J.L.; Purdy, R.E. Acquisition deficits induced by sodium nitrite in rats and mice. Psychopharmacology (Berl). 1979, 60(3):221–228. doi:10.1007/bf00426659Hansson, G.K.; Hermansson, A. The immune system in atherosclerosis. Nat Immunol. 2011, 12(3):204-212. doi: 10.1038/ni.2001Hansson, G.K.; Hermansson, A. The immune system in atherosclerosis. Nat Immunol. 2011, 12(3):204-212. doi: 10.1038/ni.2001Daugherty, A. Mouse models of atherosclerosis. Am J Med Sci. 2002, 323:3–10. doi: 10.1097/00000441-200201000-00002Daugherty, A. Mouse models of atherosclerosis. Am J Med Sci. 2002, 323:3–10. doi: 10.1097/00000441-200201000-00002Getz, G.S.; Reardon, C.A. Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol. 2006, 26(2):242-249. doi: 10.1161/01.ATV.0000201071.49029.17Getz, G.S.; Reardon, C.A. Diet and murine atherosclerosis. Arterioscler Thromb Vasc Biol. 2006, 26(2):242-249. doi: 10.1161/01.ATV.0000201071.49029.17

The authors declare that there are no conflicts of interest present.